相关实验视频
Updated: Jun 21, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
早期帕金森病未满足的需求:深度大脑刺激和怀孕
Katarzyna Smilowska1,2, Raja Mehanna3, Jori E Fleisher4
1Department of Neurology, 5th Regional Hospital, Sosnowiec, Poland.
Journal of Parkinson's disease
|July 12, 2024
概括
患有早期发病的帕金森病 (PD) 的怀孕正在增加. 这项研究为PD患者在怀孕期间深度脑刺激 (DBS) 治疗的安全性提供了临床共识.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 生殖医学 生殖医学
背景情况:
- 随着母亲年龄的增加,生育年龄与早期发病的帕金森病 (PD) 风险之间的重叠越来越大.
- 深度大脑刺激 (DBS) 越来越多地用于PD早期阶段,包括绝经前妇女.
- 关于PD患者在怀孕期间使用DBS的安全性数据有限.
研究的目的:
- 在怀孕期间对患有早期帕金森病 (PD) 的妇女进行深度大脑刺激 (DBS) 的安全性建立临床共识.
主要方法:
- 对DBS和帕金森病患者怀孕现有研究的文献综述.
- 基于现有证据和专家意见的临床共识的发展.
主要成果:
- 只有一个先前的文章讨论了PD患者怀孕期间的DBS安全性.
- 这项研究综合了当前的知识,形成了一个共识声明.
结论:
- 临床共识至关重要,因为缺乏关于DBS在怀孕期间对早期发病PD的安全性数据.
- 这一共识旨在指导临床实践,用于管理接受DBS治疗的孕妇PD患者.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.7K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.9K
相关概念视频
01:24Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251
01:15Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522